# Individualized Functional Connectivity Targeting in aiTBS for Depression

> **NCT05680727** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Depressive Disorder, Major
- Depression
- Mood Disorders
- Mental Disorder
- Psychiatric Disorder

## Interventions

- **PROCEDURE:** transcranial magnetic stimulation

## Key facts

- **NCT ID:** NCT05680727
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-15
- **Primary completion:** 2025-03-17
- **Final completion:** 2027-03-17
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05680727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05680727, "Individualized Functional Connectivity Targeting in aiTBS for Depression". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05680727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*